New Owner
Valeant Pharmaceuticals International - Sprout Pharmaceuticals
Valeant Pharmaceuticals International acquires Sprout Pharmaceuticals
Announced: August 20, 2015
Type: Acquisition
Disposition: Separate Entity
Terms: Cash
Status: Complete
Amount: $ 1,000,000,000